AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 60 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.19 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $11,442,000 | -22.1% | 5,062,759 | 0.0% | 0.74% | -34.0% |
| Q1 2018 | $14,682,000 | +3.9% | 5,062,759 | 0.0% | 1.12% | -4.8% |
| Q4 2017 | $14,125,000 | -65.8% | 5,062,759 | -55.3% | 1.18% | -68.4% |
| Q3 2017 | $41,350,000 | +120.8% | 11,328,646 | +34.3% | 3.74% | +73.8% |
| Q2 2017 | $18,727,000 | – | 8,435,584 | – | 2.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |